Fully automated in vivo screening system for multi-organ imaging and pharmaceutical evaluation. Microsystems & Nanoengineering. doi.org/10.1038/s41378-024-00852-9.

A key highlight of Okomera's presence at SLAS 2025 will be the presentation of their poster titled "End-to-End Automated Organoid Screening Platform: Application in Breast Cancer Drug Screening".

The focus is on currently available screening devices for microbial and mammalian clones, with a side-by-side comparison of established technologies to help guide informed decision-making.

MISSISSAUGA, Ontario, Dec. 09, 2021 (GLOBE NEWSWIRE) — BLOCK SOCIETY (“Block Society” or the “Society”) is pleased to announce that its Co-Founder Faris Khan, age 17 from St. James, Barbados, is ...